Yttrium-90 DOTA-TOC Intra-arterial (IA) Peptide Receptor Radionuclide Therapy (PRRT) for Neuroendocrine Tumor

NCT03197012 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Neuroendocrine Tumor

Interventions

DRUG: 90Y-DOTA-TOC
DRUG: 68Ga-DOTA-TOC

Sponsor

Thomas Hope